Individualizing therapy for metastatic colorectal cancer
Turja, J.; Grothey, A.
Oncology 22(13): 1479-1481
2008
ISSN/ISBN: 0890-9091 PMID: 19227558 Document Number: 615080
Document emailed within 1 workday
Related Documents
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954Marshall, J.L. 2014: Maintenance therapy in metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 12(6): 388-390
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Kemeny, N.E. 2000: Hepatic arterial therapy for the treatment of metastatic colorectal cancer Seminars in Oncology 27(5 Suppl 10: 126-131
Grothey, A. 2015: Maintenance therapy in the treatment of metastatic colorectal cancer. Axel Grothey, MD Oncology 29(8): 560; 594
Kato, K. 2011: Development of oral drugs in the standard therapy for metastatic colorectal cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 454-458
2013: Danitumumab adjunctive therapy. No place in either first- or second-line treatment of metastatic colorectal cancer Prescrire International 22(138): 120
Weinberg, B.A.; Marshall, J.L.; Hartley, M.; Salem, M.E. 2016: A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 14(2): 116-128
Takano, J.; Matsuhashi, N.; Takahashi, T.; Tanahashi, T.; Matsui, S.; Imai, H.; Tanaka, Y.; Yamaguchi, K.; Yoshida, K. 2018: A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 318-320
Hibi, S.; Ina, K.; Furuta, R.; Kataoka, T.; Kojima, S.; Kawai, M. 2009: Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1485-1488
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Vrdoljak, E.; Omrcen, T.; Boban, M.; Hrepic, D. 2008: Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(4): 513-518
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Saltz, L.B. 2014: Management of metastatic colorectal cancer Oncology 28(10): 841
Bartlett, D.L.; Chu, E. 2012: Can metastatic colorectal cancer be cured? Oncology 26(3): 266-275
Patanaphan, V.; Salazar, O.M. 1993: Colorectal cancer: metastatic patterns and prognosis Southern Medical Journal 86(1): 38-41
Grenon, N.N. 2011: The evolving care of metastatic colorectal cancer Oncology 25(7 Suppl Nurse Ed): 44-45
Tanada, M.; Nakata, M.; Kubo, Y.; Saeki, H.; Aogi, K.; Ishizaki, M.; Kurita, A.; Takashima, S. 2002: Pulmonary resection for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2135-2137
Govindarajan, R. 2000: Irinotecan and thalidomide in metastatic colorectal cancer Oncology 14(12 Suppl. 13): 29-32
Katsumoto, Y.; Aritake, N.; Endoh, A. 2010: The efficacy of cetuximab for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2523-2525